Immunovant (IMVT) PT Raised to $57 at Stifel
Tweet
Share
E-mailGet Alerts IMVT Hot Sheet
Price: $37.18 +0.62%
Rating Summary:
16 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Rating Summary:
16 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Join SI Premium – FREE
Stifel analyst Alex Thompson raised the price target on Immunovant (NASDAQ: IMVT) to $57.00 (from $49.00) while maintaining a Buy rating.
You May Also Be Interested In
- RBC Capital Downgrades LVMH (MC:FP) (LVMUY) to Sector Perform
- Hermes International (RMS:FP) (HESAY) PT Lowered to EUR1,600 at RBC Capital
- Bilfinger SE (GBF:GR) PT Lowered to EUR63 at Berenberg
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
